News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News FDA Approves Two Additional Indications for Rivaroxaban in Children L.A. McKeown December 21, 2021
News Daily News Adapted D-Dimer Thresholds Safe, Efficient for Acute PE Diagnosis Todd Neale December 16, 2021
News Daily News Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation Todd Neale November 25, 2021
News Daily News HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients Yael L. Maxwell October 12, 2021
News Daily News Long-term Anticoagulation After Unprovoked VTE: New Insights Shelley Wood September 13, 2021
News Daily News VTE Risk Higher After Oxford/AstraZeneca COVID-19 Vaccine, Study Affirms Todd Neale May 06, 2021
News Daily News VTE Related to SARS-CoV-2 Infection Less of a Problem in Outpatients Todd Neale April 06, 2021
News Daily News INSPIRATION: No Dip in COVID-19 Deaths or Thromboses With Higher Anticoagulation Dose L.A. McKeown March 19, 2021
News Daily News Antithrombotic Therapy for COVID-19: Challenges and Lessons for the Future L.A. McKeown March 17, 2021